show episodes
 
Artwork

1
Tenuous Tales

Paul S. Jenkins

Unsubscribe
Unsubscribe
Monthly
 
Paul S. Jenkins - host of The Rev Up Review podcast and author of the SF podcast novel The Plitone Revisionist - is writing and podcasting his current fiction. These are works in progress.
  continue reading
 
Artwork

1
Mad Influence

GQ / AT WILL MEDIA

Unsubscribe
Unsubscribe
Monthly
 
For decades, GQ magazine has convened unforgettable discussions with the world’s leading cultural figures—now that tradition takes a new form. Mad Influence, hosted by GQ’s Editor in Chief Jim Nelson, features some of the most acclaimed actors, artists, and personalities of our time in lively and revealing conversation about the decisive moments that have defined their lives and shaped their careers. Where does inspiration come from? How are creative breakthroughs achieved? And what lessons ...
  continue reading
 
Artwork

1
Voices: New Media Fiction

Mur Lafferty (editor)

Unsubscribe
Unsubscribe
Monthly
 
Voices: New Media Fiction brings together the pioneer short fiction podcasters. Experimenting from putting short-short fiction to novellas over their podcasts, these writers were the first to test the new medium for storytelling. Some wrote specifically for podcasts, some read previously published fiction, and some read entirely new stories. Some listeners asked if they could get just the stories in audio form, and that request brought about this podiobook. Cory Doctorow tells us a story abo ...
  continue reading
 
2024 Audio News and Interviews from the British Automobile Racing Club / BARC First formed in 1912 as The Cyclecar Club, today the British Automobile Racing Club organises races at almost every venue in Britain, including meetings at Anglesey, Brands Hatch, Cadwell Park, Castle Combe, Croft, Donington Park, Knockhill, Lydden Hill, Oulton Park, Pembrey, Rockingham, Silverstone, Snetterton, and of course the BARC’s home circuit, Thruxton.
  continue reading
 
Artwork

1
The Venture

Leap by McKinsey

Unsubscribe
Unsubscribe
Monthly
 
The Venture is an original podcast hosted by serial business builders from McKinsey. In each episode, our experts cut through the noise to show how leaders can launch new companies, testing their theories in conversations with legendary venture builders in Asia. We break down their journey – how they did it, the challenges they faced, how they built successful businesses.
  continue reading
 
Welcome to unleash your awesomeness. My name is Hakan Akbas & in this series of podcasts, it’s my intention and my guest’s intention, to point and nudge you in the direction of Truth, to spark the fuse within you to unleash it. There’s a good chance you may have an aha moment, an insight, it may be subtle, as a whisper or a chorus of angels. Each one of us has this awesome power within us, which is always present, running in the background, without us doing a single thing to run it. It enabl ...
  continue reading
 
Loading …
show series
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the platform business model and how it’s being used in the healthcare industry to drive innovation and reimagine ho…
  continue reading
 
Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating conditions associated with these antibodies. (00:32) Could you please give our listeners an overview of your r…
  continue reading
 
Thruxton Historic 22 - 23 June 2024 Thruxton Circuit will step back in time and reverberate to the sounds and sights of the finest Historic and Classic motor racing in the country for the annual Thruxton Historic. Now a regular on the events schedule since debuting back in 2018, the two-day meeting brings legendary machines and racers to the fastes…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss why measles remains a virus of concern, how avian flu continues to spread, and new developments in the federal regu…
  continue reading
 
Divyanshu Dubey, M.B.B.S., explains how Mayo Clinic Laboratories' unique PDE10A and TRIM46 assays facilitate care for central nervous system disorders triggered by cancer. Early diagnosis and treatment are important for managing disabling neurological symptoms and malignancy. (00:32) Could you tell us a bit about your background and your role at Ma…
  continue reading
 
The Kwik Fit British Touring Car Championship speeds into Hampshire on the 8th / 9th of June for its annual visit to the fastest circuit in the country, Thruxton. With the season gathering momentum following events at Donington Park, Brands Hatch and Snetterton, the annual visit to Thruxton is set to be crucial in the battle for supremacy towards t…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Peter Lucas, M.D., Ph.D., vice chair of Research for the Department of Laboratory Medicine and Pathology (DLMP) at Mayo Clinic. Their discussion includes: Dr. Lucas’ extensive pathology and research backgrou…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist at Mayo Clinic. They discuss the widespread outbreaks of H5N1 bird flu and the new “FLiRT” variants of COVID-1…
  continue reading
 
Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S., explain how Mayo Clinic Laboratories' augmented MayoComplete Solid Tumor Panel better profiles tumor genetics. Defining tumor pathogenesis can guide targeted cancer therapy. (00:31) Can you tell us a little about yourself and your background — Beth? (01:24) Stephanie, wh…
  continue reading
 
Rapidly progressive dementia covers many conditions, including Creutzfeldt-Jacob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' new evaluations help identify the cause of rapidly progressive dementia, to guide prognosis and treatment decisions. Show notes Speaker 3: (00:32) Can you provide a little background about…
  continue reading
 
https://pembreycircuit.co.uk/racing/british-truck-racing-championship There's a convoy coming to town! The behemoths of the British Truck Racing Championship return to the Home of Welsh Motorsport with a full support package in tow. Join us for two days of all out on-track action and off-track family entertainment for the whole family! E-TICKETS NO…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Eric Hsi, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. Their discussion includes: Dr. Hsi’s experience in the field of pathology and what he is looking forward to workin…
  continue reading
 
Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate. (00:32) Can you tell us a little bit about yourself and your background? (01:46) Can you please provide an overview of laboratory testing for substance u…
  continue reading
 
In this special episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the final rule issued by the U.S. Food and Drug Administration (FDA) on April 29, 2024, to make explicit it…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Robin Patel, M.D.,director of the Infectious Diseases Research Laboratory and co-director of the Bacteriology Laboratory at Mayo Clinic. They discuss antimicrobial resistance and why it’s a major global heal…
  continue reading
 
David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood. (00:31) Could you please provide a little bit about yourself and your backg…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss testing innovations for Alzheimer’s disease and cognitive impairments, and how laboratorians can responsibly help s…
  continue reading
 
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and about one-third of patients respond to the new medication. (00:32) Could you provide us with a little bit of …
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current events including Medical Laboratory Professionals Week, recent healthcare conferences, advocacy efforts, me…
  continue reading
 
Maria Alice Willrich, Ph.D., explains how Mayo Clinic Laboratories' new assay provides therapeutic drug monitoring of risankizumab, or RISA. Test results help guide care for patients with plaque psoriasis, psoriatic arthritis, and Crohn's disease. (00:32) Do you mind giving the audience more information about yourself and your background? (01:53) C…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to discuss tick-borne diseases and the latest testing options. Specific topics of discussion include: The types of…
  continue reading
 
Alicia Algeciras-Schimnich, Ph.D., discusses how Mayo Clinic Laboratories’ new noninvasive blood test for Alzheimer’s disease identifies the p-tau217 biomarker, which is associated with the accumulation of amyloid beta in the brain. Positive test results can facilitate access to disease-modifying therapies. (00:32): Dr. Algeciras, could you just pr…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss current events including dengue outbreaks, new colon cancer screening technology, and insurance coverage of innovat…
  continue reading
 
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing. (00:33) Do you mind giving us a brief introduction of yourself and what you do at Mayo? (01:45) Can you tell us …
  continue reading
 
The Centers for Disease Control and Prevention (CDC) issued a recent health advisory in response to the increasing number of measles outbreaks in the United States. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of lab…
  continue reading
 
Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C., explain how Mayo Clinic Laboratories' targeted test panel facilitates accurate diagnosis of hereditary pancreatitis, which heightens the risk for pancreatic cancer. Test results can guide cancer monitoring for patients and their families. (00:33) Dr. Hasadsri, can you tell the audience…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss important industry updates and legislative insights gathered from Dr. Morice’s recent trip to Washington, D.C. Thei…
  continue reading
 
Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide cancer surveillance for patients and their families. (00:32) Would each of you share a little bit about yourselves and your background? Dr. Sh…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to follow up on the syphilis epidemic and discuss updated testing recommendations. Specific topics of discussion i…
  continue reading
 
Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients in substance-use cessation programs and other settings. The serum and urine tests quantify nicotine and various metabolites. (00:32) Can you tell us a little bit about yourself and your background? (01:42) Can you please provide an overview of substance …
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the Food and Drug Administration’s (FDA) progress on making a final rule around regulating laboratory-developed tes…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to honor Black History Month. They reflect on important advancements in healthcare and laboratory medicine that were led by Blac…
  continue reading
 
The CEO of a cutting-edge fintech explain how his start-up offers investment services once reserved for the ultra-wealthy to successful professionals. As the eight cofounders of Singapore-based Arta Finance got to know one other during their years together at Google, they recognized a massive market gap for investment services aimed people like the…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Stefan Grebe, M.D., Ph.D., co-director of the Clinical Mass Spectrometry and Test Development Laboratory in the Department of Laboratory Medicine and Pathology, and Irina Bancos, M.D.,consultant in the Divis…
  continue reading
 
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy for patients, who might be as young as age 2. (00:32) Could you please tell us a little bit about your backgroun…
  continue reading
 
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss current activity of infectious diseases. Their discussion includes: Vector-borne diseases that are causing public hea…
  continue reading
 
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune liver disease. (00:32) Could you please provide a little information about your background? (02:09) Please gi…
  continue reading
 
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the blood proteins, for improved patient care and simpler test ordering. (00:32) Could you provide us with a litt…
  continue reading
 
Loading …

Quick Reference Guide